On August 6, 2018 Sotera Health LLC (“Sotera Health”), the world’s leading, fully integrated protector of global health, announced the closing of the sale of the Medical Isotopes segment within its Nordion business to a subsidiary of BWX Technologies, Inc. (“BWXT”). Nordion’s medical radioisotopes business is a leading global manufacturer and supplier of critical medical isotopes and radiopharmaceuticals for research, diagnostic, and therapeutic uses. Nordion sold essentially all of its medical isotope assets to BWXT, including the radiochemical operation and contract manufacturing services in Kanata and the medical isotope operation in Vancouver. Nordion and BWXT will continue to operate from Nordion’s state-of-the-art licensed facility in Kanata.
Fasken acted as Canadian counsel to Sotera Health and Nordion with a team comprised of Scott Conover, Ingrid VanderElst, Dan Law, Jack Yu, Rosalind Cooper, Katherine Pollock, Ross Gascho, Huy Do, Andrew Alleyne, Valerie Eisen, Ryan Shnier, Paul Casuccio and Christopher Steeves.
Fasken acted as Canadian counsel to Sotera Health and Nordion with a team comprised of Scott Conover, Ingrid VanderElst, Dan Law, Jack Yu, Rosalind Cooper, Katherine Pollock, Ross Gascho, Huy Do, Andrew Alleyne, Valerie Eisen, Ryan Shnier, Paul Casuccio and Christopher Steeves.
